| ADTX 0.0127 -2.31% | SOXS 4.72 -5.03% | SPCX 160.95 19.22% | DFNS 0.233 -9.20% | BITO 8.65 0.12% | RUBI 0.4676 -24.62% | TZA 4.16 -2.58% | CAST 1.55 140.68% | AAL 14.98 2.25% | INTC 124.57 6.51% | SPCE 3.91 -31.76% | SHFS 0.276 16.46% | SRXH 0.148 17.65% | NOK 14.795 5.00% | NVDA 205.19 0.16% | BYAH 1.47 40.00% | SPDN 8.81 -0.45% | TQQQ 77.52 1.99% | TSLL 13.59 3.58% | PAVS 0.208 -28.28% | CPOP 0.195 -81.43% | SMCI 30.46 -4.72% | CUPR 3.97 64.73% | VSME 1.69 52.25% | YYGH 0.119 -3.25% | SQQQ 40.04 -1.93% | RKLB 102.39 -10.79% | TSLA 406.43 1.82% | NVD 5.02 -0.40% | WOK 0.0753 -17.70% | SPY 741.75 0.54% | ASTS 82.41 -15.53% | KEEL 5.59 1.27% | ONDS 9.33 -5.09% | SPYM 87.06 0.25% | AMZN 238.55 -1.23% | XLF 53.34 1.37% | SATS 114.08 -10.97% | QQQ 721.34 0.59% | SOFI 16.58 -0.54% | PLUG 2.76 -2.47% | SOXL 234.68 4.77% | GRAB 3.3 -1.49% | DRIP 4.74 -2.47% | AMC 2.34 2.63% | IREN 59.77 5.40% | HKIT 0.5025 -10.11% | RKLZ 3.01 21.37% | RZLV 2.68 5.93% | MARA 14.08 3.45%

Coca-Cola Europacific Partners PLC (NASDAQ:CCEP) Financial Overview and Analyst Insights

Coca-Cola Europacific Partners PLC (NASDAQ:CCEP) is a key player in the non-alcoholic beverage industry, offering a diverse range of products under renowned brands like Coca-Cola, Fanta, Sprite, and Monster Energy. The company serves around 600 million consumers, establishing a strong foothold in the beverage market. CCEP's extensive operations and brand portfolio position it as a significant entity in the consumer staples sector.

The consensus price target for CCEP's stock has shown fluctuations over different periods. Last month, the average price target was $101, while last quarter it was higher at $107.5. A year ago, the target was $104.33. These variations suggest that analysts have adjusted their expectations, possibly due to recent developments or market conditions affecting CCEP's stock valuation.

In the third quarter ending September 26, 2025, CCEP reported a solid performance, with total revenue reaching €5.41 billion. This included a 0.4% increase in volume and a 2.7% rise in revenue per unit case. In Europe, revenue was €4.19 billion, with a 0.9% increase in comparable volume. The Asia Pacific and South region saw revenue of €1.22 billion, with a slight decline in volume.

Despite these positive results, UBS analyst Robert Krankowski has set a price target of $68 for CCEP, indicating a more cautious outlook. The company's current valuation reflects its fundamental strength, but the near-term risk/reward profile is less attractive. CCEP's scale, exclusive partnership with Coca-Cola, and focus on high-value categories provide a durable competitive advantage, supporting a positive long-term outlook.

CCEP's financial performance in the first half of 2025 was strong, with revenue of €10.3 billion, a 4.5% increase from the previous year. Operating profit rose by 19.4% to €1.36 billion, and diluted earnings per share increased by 15% to €1.99. The company has reaffirmed its full-year profit and cash guidance, indicating confidence in its ongoing financial health.

Published on: February 16, 2026